These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32142606)

  • 1. Rapid and Simultaneous Characterization of Drug Conjugation in Heavy and Light Chains of a Monoclonal Antibody Revealed by High-Resolution Ion Mobility Separations in SLIM.
    Nagy G; Attah IK; Conant CR; Liu W; Garimella SVB; Gunawardena HP; Shaw JB; Smith RD; Ibrahim YM
    Anal Chem; 2020 Apr; 92(7):5004-5012. PubMed ID: 32142606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Ion Mobility Mass Spectrometry for Drug-to-Antibody Ratio Measurements in Antibody-Drug Conjugates.
    Huang RY; Deyanova EG; Passmore D; Rangan V; Deshpande S; Tymiak AA; Chen G
    J Am Soc Mass Spectrom; 2015 Oct; 26(10):1791-4. PubMed ID: 26122520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
    Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.
    Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W
    MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate.
    Marcoux J; Champion T; Colas O; Wagner-Rousset E; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Protein Sci; 2015 Aug; 24(8):1210-23. PubMed ID: 25694334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates.
    Wu G; Yu C; Yin S; Du J; Zhang Y; Fu Z; Wang L; Wang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124167. PubMed ID: 38823148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Intact Antibody Drug Conjugate Variants Using Microfluidic Capillary Electrophoresis-Mass Spectrometry.
    Redman EA; Mellors JS; Starkey JA; Ramsey JM
    Anal Chem; 2016 Feb; 88(4):2220-6. PubMed ID: 26765745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Analysis of Reduced Antibody Drug Conjugate by Online LC-MS/MS with Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
    Larson EJ; Zhu Y; Wu Z; Chen B; Zhang Z; Zhou S; Han L; Zhang Q; Ge Y
    Anal Chem; 2020 Nov; 92(22):15096-15103. PubMed ID: 33108180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry.
    Xu K; Liu L; Saad OM; Baudys J; Williams L; Leipold D; Shen B; Raab H; Junutula JR; Kim A; Kaur S
    Anal Biochem; 2011 May; 412(1):56-66. PubMed ID: 21216214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioanalysis in the development of antibody-drug conjugates].
    Li XL; Chen XY; Zhong DF
    Yao Xue Xue Bao; 2016 Apr; 51(4):517-28. PubMed ID: 29859519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calculated conjugated payload from immunoassay and LC-MS intact protein analysis measurements of antibody-drug conjugate.
    Rago B; Clark T; King L; Zhang J; Tumey LN; Li F; Barletta F; Wei C; Leal M; Hansel S; Han X
    Bioanalysis; 2016 Nov; 8(21):2205-2217. PubMed ID: 27682846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of drug load variants in a thiol linked antibody-drug conjugate using multidimensional chromatography.
    Gilroy JJ; Eakin CM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():182-189. PubMed ID: 28622622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic Time-Warping Correction for Shifts in Ultrahigh Resolving Power Ion Mobility Spectrometry and Structures for Lossless Ion Manipulations.
    Hollerbach AL; Conant CR; Nagy G; Monroe ME; Gupta K; Donor M; Giberson CM; Garimella SVB; Smith RD; Ibrahim YM
    J Am Soc Mass Spectrom; 2021 Apr; 32(4):996-1007. PubMed ID: 33666432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of ADCs by Native Mass Spectrometry.
    Hernandez-Alba O; Ehkirch A; Beck A; Cianférani S
    Methods Mol Biol; 2020; 2078():197-211. PubMed ID: 31643058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Drug Conjugation and Loading on Target Antigen Binding and Cytotoxicity in Cysteine Antibody-Drug Conjugates.
    Nadkarni DV; Lee J; Jiang Q; Patel V; Sriskanda V; Dutta K; Meyer DM
    Mol Pharm; 2021 Mar; 18(3):889-897. PubMed ID: 33470823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of antibody-drug conjugates by mass spectrometry: advances and future trends.
    Huang RY; Chen G
    Drug Discov Today; 2016 May; 21(5):850-5. PubMed ID: 27080148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLIM Ultrahigh Resolution Ion Mobility Spectrometry Separations of Isotopologues and Isotopomers Reveal Mobility Shifts due to Mass Distribution Changes.
    Wojcik R; Nagy G; Attah IK; Webb IK; Garimella SVB; Weitz KK; Hollerbach A; Monroe ME; Ligare MR; Nielson FF; Norheim RV; Renslow RS; Metz TO; Ibrahim YM; Smith RD
    Anal Chem; 2019 Sep; 91(18):11952-11962. PubMed ID: 31450886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific antibody-drug conjugate heterogeneity characterization and heterogeneity root cause analysis.
    Cao M; De Mel N; Jiao Y; Howard J; Parthemore C; Korman S; Thompson C; Wendeler M; Liu D
    MAbs; 2019; 11(6):1064-1076. PubMed ID: 31198090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Loading and Distribution of ADCs After Reduction or IdeS Digestion and Reduction.
    Wagner-Rousset E; Colas O; François YN; Heinisch S; Guillarme D; Cianférani S; Beck A
    Methods Mol Biol; 2020; 2078():187-195. PubMed ID: 31643057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry.
    Friese OV; Smith JN; Brown PW; Rouse JC
    MAbs; 2018 Apr; 10(3):335-345. PubMed ID: 29393747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.